Avai Bio (AVAI) Shares Outstanding (2018 - 2023)
Avai Bio's Shares Outstanding history spans 5 years, with the latest figure at $84.8 million for Q4 2023.
- For Q4 2023, Shares Outstanding rose 163.08% year-over-year to $84.8 million; the TTM value through Dec 2023 reached $84.8 million, up 163.08%, while the annual FY2023 figure was $38.5 million, N/A changed from the prior year.
- Shares Outstanding for Q4 2023 was $84.8 million at Avai Bio, up from $74.3 million in the prior quarter.
- Across five years, Shares Outstanding topped out at $84.8 million in Q4 2023 and bottomed at $1.1 million in Q1 2020.
- The 4-year median for Shares Outstanding is $26.3 million (2020), against an average of $28.8 million.
- The largest YoY upside for Shares Outstanding was 424.16% in 2020 against a maximum downside of 78.78% in 2020.
- A 4-year view of Shares Outstanding shows it stood at $5.0 million in 2019, then changed by 0.0% to $5.0 million in 2020, then surged by 542.81% to $32.2 million in 2022, then surged by 163.08% to $84.8 million in 2023.
- Per Business Quant, the three most recent readings for AVAI's Shares Outstanding are $84.8 million (Q4 2023), $74.3 million (Q3 2023), and $64.5 million (Q2 2023).